Monoterapia versus combinaciones en sepsis beta lactam monotherapy versus b-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Br Med J 2004; 328: 668-82
Guardado en:
Autor principal: | Zamorano R.,Juanita |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Chilena de Infectología
2004
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000300014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
por: Paul Skorup, et al.
Publicado: (2014) -
In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams.
por: Fiona Fouhy, et al.
Publicado: (2013) -
Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
por: Dimard E. Foudraine, et al.
Publicado: (2021) -
Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site
por: Zainab Edoo, et al.
Publicado: (2017) -
Amide nitrogen pyramidalization changes lactam amide spinning
por: Yuko Otani, et al.
Publicado: (2019)